Vivo Ventures LLC, of Palo Alto, Calif., promoted Chen Yu and James Zhao to managing partners...Xceleron Ltd., of York, UK, appointed David Roblin to its board and named Stuart Best senior director of operations...XOMA Ltd., of Berkeley, Calif., appointed Paul Rubin vice president and chief medical officer

Spectrum Pharmaceuticals Inc., of Henderson, Nev., promoted Steven M. Fruchtman to vice president and chief medical officer and Nozar Azarnia to vice president of biostatistics and data management...Tetragenetics Inc., of Cambridge, Mass., appointed Marco Cacciuttolo president and CEO...It also named Ben Machielse and Robert Gailus to its board

Co-founder Douglas P. Clark was named chief medical officer and acting CEO, effective July 1...Compass Biotechnologies Inc., of Edmonton, Alberta, appointed Joseph Sinkule president and chief operating officer...Cytochroma Inc., of Markham, Ontario, appointed Cynthia Lavoie and Osamu Otani to its board

The firm also nominated Stuart Strathdee and Ganesh Kishore to its board...Immune Design Corp., of Seattle, named Carlos V. Paya CEO and board member...Medivation Inc., of San Francisco, appointed Gretchen Burke vice president of finance and business processes

An item in the May 19, 2011, edition of BioWorld Today's Appointments and Advancements column should have said that Adimab LLC appointed Frances Heller to its board

Neoprobe Corp., of Dublin, Ohio, appointed Mark Pykett president and CEO...Regulus Therapeutics Inc., of La Jolla, Calif., named Lars Karlsson vice president of immunology and fibrosis...Tobira Therapeutics Inc., of Manalapan, N.J., named Andrew Hindman president and CEO

Access Pharmaceuticals Inc., of Dallas, named Anthony Mottola vice president of managed care and market access...Actelion Ltd., of Allschwil, Switzerland, nominated Jean-Pierre Garnier and Robert Bertolini to its board...Ampio Pharmaceuticals Inc., of Greenwood Village, Colo., appointed Mark D. McGregor chief financial officer and corporate secretary

Hospira Inc., of Lake Forest, Ill., elected F. Michael (Mike) Ball CEO and board member...ITherX Pharmaceuticals Inc., of San Diego, named Stefan Zeuzem chairman of its scientific and clinical advisory board

Addex Pharmaceuticals Ltd., of Geneva, proposed adding Hoyoung Huh and Oleg Nodelman to the board...Codexis Inc., of Redwood City, Calif., named Jacques Beaudry-Losique vice president of corporate development and strategy

ATyr Pharma, of San Diego, formed a therapeutic advisory board comprising Thomas O. Daniel, L. Patrick Gage, Rich Heyman, Keith James, Paul Negulescu, Timothy Rink, Wendell Wierenga and Doug Williams...Otonomy Inc., of San Diego, appointed G. Michael Wall vice president of product development and named Cindy Berejikian vice president of program management

BioNanomatrix Inc., of Philadelphia, named R. Erik Holmlin president, CEO and director...It also added Michael Handelman as chief financial officer, treasurer and secretary...Medgenics Inc., of Misgav, Israel, added Isaac Blech and Raymond Dean Hautamaki to its board

The firm also named Lori M. Henderson vice president, general counsel and secretary...Anadys Pharmaceuticals Inc., of San Diego, named Kevin L. Eastwood senior vice president of corporate development, promoted James Appleman to senior vice president of research and chief scientific officer, appointed James L. Freddo to the board and named Stelios Papadopoulos chairman...AspenBio Pharma Inc., of Castle Rock, Colo., added Erik S. Miller as vice president of marketing and business development

Markus Leyck Dieken senior vice president and general manager, Germany...and Manuela Maronati vice president, sales and marketing, Europe

OctoPlus NV, of Leiden, the Netherlands, named Jan Hendrik Egberts and nominated him for appointment as CEO...Optimer Pharmaceuticals Inc., of San Diego, named Kurt Hartman general counsel and access...Protox Therapeutics Inc., of Vancouver, British Columbia, named Lars Ekman chairman and added Jonathan Leff and Nishan de Silva to the board

Celtaxys Inc., of Atlanta, named Michael Hanley CEO and chairman...Codexis Inc., Redwood City, Calif., named William Rothwell vice president and general manager of Biobased Chemicals...Cytomedix Inc., of Gaithersburg, Md., formed a scientific advisory board with the appointments of Marissa Carter, Jean de Leon, Vickie R. Driver, Peter A. M. Everts, Will W. Li and Thomas E. Serena

plc, of Dublin, Ireland, appointed Kristine Peterson to its board and named Joseph S. Zakrzewski CEO...Ambit Biosciences Corp., of San Diego, named Faheem Hasnain chairman and appointed Alan Fuhrman chief financial officer...AnaptysBio Inc., of San Diego, named Jan de Vries, Nicholas B. Lydon and Phillip A. Patten to its scientific and therapeutic advisory boards

Roche, of Nutley, N.J., named Jacques Banchereau senior vice president and head of the inflammation and virology discovery and translational areas

Neovacs, of Paris, appointed Florence Hocdee-Leroy communications and investor relations director...Oligomerix Inc., of New York, appointed Vic Micati chairman and named Jack Pasini chief commercial officer and board member

Accera Inc., of Broomfield, Colo., appointed Thomas Werner president and CEO...Agile Therapeutics Inc., of Princeton, N.J., named Al Altomari president and CEO...AIKO Biotechnology, of Portland, Maine, appointed Jim New CEO and added Paul Goldenheim to its board